262 related articles for article (PubMed ID: 20445553)
1. PD-1 on immature and PD-1 ligands on migratory human Langerhans cells regulate antigen-presenting cell activity.
Peña-Cruz V; McDonough SM; Diaz-Griffero F; Crum CP; Carrasco RD; Freeman GJ
J Invest Dermatol; 2010 Sep; 130(9):2222-30. PubMed ID: 20445553
[TBL] [Abstract][Full Text] [Related]
2. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.
Brown JA; Dorfman DM; Ma FR; Sullivan EL; Munoz O; Wood CR; Greenfield EA; Freeman GJ
J Immunol; 2003 Feb; 170(3):1257-66. PubMed ID: 12538684
[TBL] [Abstract][Full Text] [Related]
3. Human langerhans cells are more efficient than CD14(-)CD1c(+) dermal dendritic cells at priming naive CD4(+) T cells.
Furio L; Briotet I; Journeaux A; Billard H; Péguet-Navarro J
J Invest Dermatol; 2010 May; 130(5):1345-54. PubMed ID: 20107482
[TBL] [Abstract][Full Text] [Related]
4. Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses.
Bennett F; Luxenberg D; Ling V; Wang IM; Marquette K; Lowe D; Khan N; Veldman G; Jacobs KA; Valge-Archer VE; Collins M; Carreno BM
J Immunol; 2003 Jan; 170(2):711-8. PubMed ID: 12517932
[TBL] [Abstract][Full Text] [Related]
5. Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal.
Fife BT; Pauken KE; Eagar TN; Obu T; Wu J; Tang Q; Azuma M; Krummel MF; Bluestone JA
Nat Immunol; 2009 Nov; 10(11):1185-92. PubMed ID: 19783989
[TBL] [Abstract][Full Text] [Related]
6. PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2.
Carter L; Fouser LA; Jussif J; Fitz L; Deng B; Wood CR; Collins M; Honjo T; Freeman GJ; Carreno BM
Eur J Immunol; 2002 Mar; 32(3):634-43. PubMed ID: 11857337
[TBL] [Abstract][Full Text] [Related]
7. Variable increased expression of program death-1 and program death-1 ligands on peripheral mononuclear cells is not impaired in patients with systemic lupus erythematosus.
Liu MF; Weng CT; Weng MY
J Biomed Biotechnol; 2009; 2009():406136. PubMed ID: 19759858
[TBL] [Abstract][Full Text] [Related]
8. The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands.
Kinter AL; Godbout EJ; McNally JP; Sereti I; Roby GA; O'Shea MA; Fauci AS
J Immunol; 2008 Nov; 181(10):6738-46. PubMed ID: 18981091
[TBL] [Abstract][Full Text] [Related]
9. Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis.
Jurado JO; Alvarez IB; Pasquinelli V; Martínez GJ; Quiroga MF; Abbate E; Musella RM; Chuluyan HE; García VE
J Immunol; 2008 Jul; 181(1):116-25. PubMed ID: 18566376
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues.
Ishida M; Iwai Y; Tanaka Y; Okazaki T; Freeman GJ; Minato N; Honjo T
Immunol Lett; 2002 Oct; 84(1):57-62. PubMed ID: 12161284
[TBL] [Abstract][Full Text] [Related]
11. Human NKT cells direct the differentiation of myeloid APCs that regulate T cell responses via expression of programmed cell death ligands.
Hegde S; Lockridge JL; Becker YA; Ma S; Kenney SC; Gumperz JE
J Autoimmun; 2011 Aug; 37(1):28-38. PubMed ID: 21486688
[TBL] [Abstract][Full Text] [Related]
12. Differential role of programmed death-ligand 1 [corrected] and programmed death-ligand 2 [corrected] in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis.
Zhu B; Guleria I; Khosroshahi A; Chitnis T; Imitola J; Azuma M; Yagita H; Sayegh MH; Khoury SJ
J Immunol; 2006 Mar; 176(6):3480-9. PubMed ID: 16517716
[TBL] [Abstract][Full Text] [Related]
13. Differential binding properties of B7-H1 and B7-DC to programmed death-1.
Youngnak P; Kozono Y; Kozono H; Iwai H; Otsuki N; Jin H; Omura K; Yagita H; Pardoll DM; Chen L; Azuma M
Biochem Biophys Res Commun; 2003 Aug; 307(3):672-7. PubMed ID: 12893276
[TBL] [Abstract][Full Text] [Related]
14. Expression of programmed death 1 ligands by murine T cells and APC.
Yamazaki T; Akiba H; Iwai H; Matsuda H; Aoki M; Tanno Y; Shin T; Tsuchiya H; Pardoll DM; Okumura K; Azuma M; Yagita H
J Immunol; 2002 Nov; 169(10):5538-45. PubMed ID: 12421930
[TBL] [Abstract][Full Text] [Related]
15. Human decidual stromal cells suppress cytokine secretion by allogenic CD4+ T cells via PD-1 ligand interactions.
Nagamatsu T; Schust DJ; Sugimoto J; Barrier BF
Hum Reprod; 2009 Dec; 24(12):3160-71. PubMed ID: 19729380
[TBL] [Abstract][Full Text] [Related]
16. PD-L2 is a second ligand for PD-1 and inhibits T cell activation.
Latchman Y; Wood CR; Chernova T; Chaudhary D; Borde M; Chernova I; Iwai Y; Long AJ; Brown JA; Nunes R; Greenfield EA; Bourque K; Boussiotis VA; Carter LL; Carreno BM; Malenkovich N; Nishimura H; Okazaki T; Honjo T; Sharpe AH; Freeman GJ
Nat Immunol; 2001 Mar; 2(3):261-8. PubMed ID: 11224527
[TBL] [Abstract][Full Text] [Related]
17. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation.
Freeman GJ; Long AJ; Iwai Y; Bourque K; Chernova T; Nishimura H; Fitz LJ; Malenkovich N; Okazaki T; Byrne MC; Horton HF; Fouser L; Carter L; Ling V; Bowman MR; Carreno BM; Collins M; Wood CR; Honjo T
J Exp Med; 2000 Oct; 192(7):1027-34. PubMed ID: 11015443
[TBL] [Abstract][Full Text] [Related]
18. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation.
Kanai T; Totsuka T; Uraushihara K; Makita S; Nakamura T; Koganei K; Fukushima T; Akiba H; Yagita H; Okumura K; Machida U; Iwai H; Azuma M; Chen L; Watanabe M
J Immunol; 2003 Oct; 171(8):4156-63. PubMed ID: 14530338
[TBL] [Abstract][Full Text] [Related]
19. siRNA knockdown of PD-L1 and PD-L2 in monocyte-derived dendritic cells only modestly improves proliferative responses to Gag by CD8(+) T cells from HIV-1-infected individuals.
Breton G; Yassine-Diab B; Cohn L; Boulassel MR; Routy JP; Sékaly RP; Steinman RM
J Clin Immunol; 2009 Sep; 29(5):637-45. PubMed ID: 19562472
[TBL] [Abstract][Full Text] [Related]
20. Programmed Death-Ligand 1 on Antigen-presenting Cells Facilitates the Induction of Antigen-specific Cytotoxic T Lymphocytes: Application to Adoptive T-Cell Immunotherapy.
Goto T; Nishida T; Takagi E; Miyao K; Koyama D; Sakemura R; Hanajiri R; Watanabe K; Imahashi N; Terakura S; Murata M; Kiyoi H
J Immunother; 2016 Oct; 39(8):306-15. PubMed ID: 27548033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]